Polyrizon (PLRZ) Stock

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

Israel

IPO:

29 October 2024

Indexes:

Not included

Description:

Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a containment barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

N/A

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

No data about analysts updates

Screeners with PLRZ included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

FAQ

  • What is the primary business of Polyrizon?
  • What is the ticker symbol for Polyrizon?
  • Does Polyrizon pay dividends?
  • What sector is Polyrizon in?
  • What industry is Polyrizon in?
  • What country is Polyrizon based in?
  • When did Polyrizon go public?
  • Is Polyrizon in the S&P 500?
  • Is Polyrizon in the NASDAQ 100?
  • Is Polyrizon in the Dow Jones?
  • When does Polyrizon report earnings?

What is the primary business of Polyrizon?

Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a containment barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.

What is the ticker symbol for Polyrizon?

The ticker symbol for Polyrizon is NASDAQ:PLRZ

Does Polyrizon pay dividends?

No, Polyrizon does not pay dividends

What sector is Polyrizon in?

Polyrizon is in the Healthcare sector

What industry is Polyrizon in?

Polyrizon is in the Biotechnology industry

What country is Polyrizon based in?

Polyrizon is headquartered in Israel

When did Polyrizon go public?

Polyrizon's initial public offering (IPO) was on 29 October 2024

Is Polyrizon in the S&P 500?

No, Polyrizon is not included in the S&P 500 index

Is Polyrizon in the NASDAQ 100?

No, Polyrizon is not included in the NASDAQ 100 index

Is Polyrizon in the Dow Jones?

No, Polyrizon is not included in the Dow Jones index

When does Polyrizon report earnings?

The date for Polyrizon's next earnings report has not been announced yet